跳至主要内容
临床试验/NCT05593640
NCT05593640招募中不适用

Throboxane Effect on Chondrocytes; Role in Osteoarthritis

Centre Hospitalier Universitaire de Nice1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2022年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
20
试验地点
1
主要终点
to look for correlation between the rate of throboxane and the grade of osteoarthritis

研究概览

简要总结

TXA2 inhibits the expression of the primary marker of thermogenesis (UCP1) while prostacyclin (PGI2), another metabolite derived from arachidonic acid, enhances its expression. Given the close relationship between the adipocyte and the chondrocyte, the study team hypothesises that thromboxane A2 controls chondrocyte formation and function and thus cartilage homeostasis. The study objectives are: i) to analyse the role of TXA2 on chondrocyte differentiation in vitro, ii) to determine the association between circulating and tissue TXA2 levels in a rat model of osteoarthritis, and iii) to correlate circulating and synovial fluid levels of TXA2 with the development of osteoarthritis in a small human cohort. The proposed research aims to better understand the mechanisms underlying the role of lipid metabolites in chondrocyte formation and function, paving the way for the development of nutritional and pharmacological therapies to combat OA and associated metabolic disorders.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • presence of knee osteoarthritis with effusion, , no inflammatory disease

排除标准

  • anticoagulant treatment
  • inflammatory disease

研究组 & 干预措施

ThroboxaneOA

Patient with osteoarthritis and knee effusion

干预措施: biological samples (Other)

结局指标

主要结局

to look for correlation between the rate of throboxane and the grade of osteoarthritis

时间窗: 6 months

kellgren and lawrence classification

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Thromboxane A2 and Osteoarthritis | 临床试验